NOTCH pathway inactivation promotes bladder cancer progression - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Journal of Clinical Investigation Année : 2015

NOTCH pathway inactivation promotes bladder cancer progression


NOTCH signaling suppresses tumor growth and proliferation in several types of stratified epithelia. Here, we show that missense mutations in NOTCH1 and NOTCH2 found in human bladder cancers result in loss of function. In murine models, genetic ablation of the NOTCH pathway accelerated bladder tumorigenesis and promoted the formation of squamous cell carcinomas, with areas of mesenchymal features. Using bladder cancer cells, we determined that the NOTCH pathway stabilizes the epithelial phenotype through its effector HES1 and, consequently, loss of NOTCH activity favors the process of epithelial-mesenchymal transition. Evaluation of human bladder cancer samples revealed that tumors with low levels of HES1 present mesenchymal features and are more aggressive. Together, our results indicate that NOTCH serves as a tumor suppressor in the bladder and that loss of this pathway promotes mesenchymal and invasive features.


Fichier principal
Vignette du fichier
JCI78185.pdf (2.09 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-02277493 , version 1 (03-09-2019)



Antonio Maraver, Pablo Fernandez-Marcos, Timothy Cash, Marinela Mendez-Pertuz, Marta Dueñas, et al.. NOTCH pathway inactivation promotes bladder cancer progression. Journal of Clinical Investigation, 2015, 125 (2), pp.824-830. ⟨10.1172/JCI78185⟩. ⟨hal-02277493⟩
80 Consultations
84 Téléchargements



Gmail Mastodon Facebook X LinkedIn More